Revolution Medicines to Host Investor Conference Call on Positive RASolute 302 Results Following 2026 ASCO Presentation

Go back to Revolution Medicines to Host Investor Conference Call on Positive RASolute 302 Results Following 2026 ASCO Presentation
(NASDAQ: RVMD) Delayed: 165.81 +2.82 (1.73%)
Previous Close $162.99    52 Week High
Open $162.32    52 Week Low
Day High $166.84    P/E N/A 
Day Low $162.15    EPS
Volume 3,128,201